Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05034263 · ClinicalTrials.gov registry record
Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease
A clinical trial, sponsored by Stony Brook University.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05034263: Clinical Trial study, sponsored by Stony Brook University.
NCT05034263 is a clinical trial that was terminated before completion, run by Stony Brook University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05034263 was terminated before completion, sponsored by Stony Brook University.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This is an imaging study designed to illuminate the function of the cholinergic system and its association with cognitive skills in people with Parkinson's disease. The hypothesis of this study is that there will be an association between cholinergic terminal density, sex hormones, and cognitive functioning. Participants will receive a PET and MRI scan along with a battery of neurocognitive tests at baseline and again at 18 months follow-up. Hormone levels will be measured at baseline.
Primary Outcome
Measured by PET scan 18F\[VAT\] distribution volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2024-05-27 |
Why NCT05034263 stopped before completion
NCT05034263 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05034263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05034263 about?
NCT05034263 is a clinical study titled "Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease". This is an imaging study designed to illuminate the function of the cholinergic system and its association with cognitive skills in people with Parkinson's disease. The hypothesis of this study is that there will be an association between cholinergic terminal density, sex hormones, and cognitive fun...
What is the current status of trial NCT05034263?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2021-05-27. Estimated completion is 2024-05-27.
Who is sponsoring clinical trial NCT05034263?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI